ZBIO insider transactions
Zenas BioPharma Inc. (ZBIO) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
ZBIO insiders
Everyone who has filed a Form 4 or 5 at Zenas BioPharma Inc., latest first. Follow anyone to get their next filing.
- Christy J. OligerDirector
- Jason Raleigh NunnDirector+$16.2M
- Hongbo LuDirector+$9.15M
- Leon O Moulder JrChief Executive Officer, Director+$7.93M
- John J OrloffDirector
- Lisa von MoltkeOfficer
- Patricia L AllenDirector+$500K
- James P BoylanDirector
- Patrick G EnrightDirector+$9.73M
- Joseph L FarmerOfficer
- Jennifer A. FoxOfficer
- Fairmount Funds Management LLCDirector+$19.2M
- Sr One Capital Management, LLC10% owner+$40.4M
- Orlando OliveiraChief Commercial Officer
- Ting XiaoDirector+$155K
Recent Form 3, 4, and 5 filings for ZBIO
- New insider Innocare Pharma Inc. claimed ownership of 7,000,000 shares (SEC Form 3)3 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Director Oliger Christy J.4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 3 filed by new insider Oliger Christy J.3 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Director Nunn Jason Raleigh4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Director Lu Hongbo4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Officer Moulder Leon O Jr4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Director Orloff John J4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Officer Von Moltke Lisa4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Director Allen Patricia L4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Director Boylan James P4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Director Enright Patrick G4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- Officer Farmer Joseph L was granted 974 shares (SEC Form 4)4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- Officer Fox Jennifer A. was granted 1,592 shares (SEC Form 4)4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- Chief Executive Officer Moulder Leon O Jr bought $1,012,800 worth of shares (60,000 units at $16.88) (SEC Form 4)4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- Chief Executive Officer Moulder Leon O Jr bought $1,067,200 worth of shares (60,000 units at $17.79) (SEC Form 4)4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Lu Hongbo4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Fairmount Funds Management Llc4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Moulder Leon O Jr4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Lu Hongbo4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- Director Lu Hongbo bought $584,662 worth of shares (25,985 units at $22.50) (SEC Form 4)4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- Director Allen Patricia L bought $499,746 worth of shares (19,860 units at $25.16) (SEC Form 4)4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- Chief Executive Officer Moulder Leon O Jr bought $1,023,720 worth of shares (57,000 units at $17.96), increasing direct ownership by 16% to 423,155 units (SEC Form 4)4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- Chief Executive Officer Moulder Leon O Jr bought $1,639,000 worth of shares (100,000 units at $16.39), increasing direct ownership by 38% to 366,155 units (SEC Form 4)4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- New insider Innocare Pharma Inc. claimed ownership of 5,000,000 shares (SEC Form 3)3 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- Director Nunn Jason Raleigh bought $1,200,002 worth of shares (63,158 units at $19.00) (SEC Form 4)4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- Large owner Sr One Capital Management, Llc bought $2,399,985 worth of shares (126,315 units at $19.00) (SEC Form 4)4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- Director Enright Patrick G bought $2,250,026 worth of shares (117,255 units at $19.19) (SEC Form 4)4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- Officer Moulder Leon O Jr bought $769,949 worth of shares (36,928 units at $20.85) (SEC Form 4)4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- Director Fairmount Funds Management Llc bought $6,008,161 worth of shares (316,219 units at $19.00) (SEC Form 4)4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- Director Lu Hongbo bought $6,000,031 worth of shares (321,983 units at $18.63) (SEC Form 4)4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Director Nunn Jason Raleigh4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Officer Fox Jennifer A.4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Officer Oliveira Orlando4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Director Boylan James P4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Director Allen Patricia L4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Officer Farmer Joseph L4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Director Fairmount Funds Management Llc4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Director Enright Patrick G4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Director Orloff John J4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Director Lu Hongbo4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Officer Moulder Leon O Jr4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- Amendment: Director Xiao Ting bought $77,600 worth of shares (10,000 units at $7.76) (SEC Form 4)4/A - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Officer Von Moltke Lisa4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 3 filed by new insider Von Moltke Lisa3 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- Chief Executive Officer Moulder Leon O Jr bought $166,750 worth of shares (25,000 units at $6.67), increasing direct ownership by 10% to 266,155 units (SEC Form 4)4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- Director Xiao Ting bought $77,600 worth of shares (10,000 units at $7.76), increasing direct ownership by 27% to 47,000 units (SEC Form 4)4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Officer Fox Jennifer A.4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Chief Commercial Officer Oliveira Orlando4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- Chief Executive Officer Moulder Leon O Jr bought $718,100 worth of shares (70,000 units at $10.26), increasing direct ownership by 41% to 241,155 units (SEC Form 4)4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- Chief Executive Officer Moulder Leon O Jr bought $148,925 worth of shares (10,000 units at $14.89), increasing direct ownership by 6% to 171,155 units (SEC Form 4)4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- Chief Executive Officer Moulder Leon O Jr bought $360,820 worth of shares (20,000 units at $18.04) (SEC Form 4)4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- Amendment: Director Fairmount Funds Management Llc converted options into 1,304,891 shares and bought $5,100,000 worth of shares (300,000 units at $17.00) (SEC Form 4)4/A - Zenas BioPharma, Inc. (0001953926) (Issuer)
- Amendment: Chief Executive Officer Moulder Leon O Jr converted options into 693,175 shares, increasing direct ownership by 3,465% to 161,155 units (SEC Form 4)4/A - Zenas BioPharma, Inc. (0001953926) (Issuer)
- Director Lu Hongbo bought $999,991 worth of shares (58,823 units at $17.00) (SEC Form 4)4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Director Orloff John J4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Director Xiao Ting4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Director Lu Hongbo4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Director Allen Patricia L4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- Director Enright Patrick G converted options into 2,061,934 shares and bought $7,480,000 worth of shares (440,000 units at $17.00) (SEC Form 4)4 - Zenas BioPharma, Inc. (0001953926) (Issuer)
- SEC Form 4 filed by Director Boylan James P4 - Zenas BioPharma, Inc. (0001953926) (Issuer)